Plenary Session: Plenary Session 2: State-of-the-Art technologies 1
Thursday October 23, 2025 from 11:00 to 12:30
Main Hall
Moderators
Lectures
-
11:00 - 11:4502.1 Hepatocyte‑intrinsic, self‑assembling secretome defines the tissue microenvironmentDr. Takeshi Saito, United States
-
11:45 - 12:3002.2 CRISPR/Cas9 technology: a potential therapeutic approach for targeting the supernumerary chromosome in Down syndromeDr. Ryotaro Hashizume, Japan